1-24 of 235 Books

Estrogens, Progestins, and Their Antagonists
By Edward J. Pavlik

Cardiovascular effects of dihydropyridine-type calcium antagonists and agonists
By Bayer-Symposium (9th 1984 Boppard, Germany),A. Fleckenstein,C. Van Breemen,R. Grob

Clinical use of calcium channel antagonist drugs
By Opie, Lionel H.
Calcium antagonists
Calcium antagonists
By Robert A. Lehnhard

Negative regulators of hematopoiesis
By Athanasius Anagnostou,Nicholas Dainiak,Albert Najman

Pharmacological control of calcium and potassium homeostasis
By T. Godfraind

Calcium entry blockers in cardiovascular and cerebral dysfunctions
By T. Godfraind

Adenosine receptors and Parkinson's disease
By Peter Jenner

Inhibitors to coagulation factors
By Louis M. Aledort

Serotonin-related Psychiatric Syndromes
By Giovanni B. Cassano
Inhibition of Folate Metabolism in Chemotherapy
Inhibition of Folate Metabolism in Chemotherapy
By G. H. Hitchings

Receptor Medicated Antisteroid Action
By M. K. Agarwal

Selective 5-Ht Reuptake Inhibitors
By M. Gastpar

Opiate Receptors and Antagonists
By Reginald Dean

Endothelin and Its Inhibitors
By Timothy D. Warner

Pharmacology of ionic channel function
By M. Endo
Aromatase inhibitors
Aromatase inhibitors
By Jean R. Lamonte

RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States
By United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology.

Folyl and antifolyl polyglutamates
By I. David Goldman,Joseph R. Bertino,Bruce Chabner